Understanding Immune in Immune Thrombocytopenia
Episode description
Immune thrombocytopenia, the ITP is increasingly recognized as a complex immune‑mediated disease rather than just a disorder of low platelets. This episode, explores new developments in ITP, focusing on the complex immune disorder as the underlying mechanism of ITP and how immunological mechanisms translate into the diverse clinical manifestations seen in clinical practice.
Expert guests in this episode are:
Henrik Frederiksen, is a Consultant Hematologist and Clinical Professor at Odense University Hospital and University of Southern Denmark. He is an expert in benign hematology, particularly immune thrombocytopenia (ITP), and autoimmune hemolytic anemia (AIHA), and is an active contributor to EHA guideline development.
Rick Kapur, MD, PhD, MSc, is a research group leader at Sanquin Blood Supply Foundation, Department Research, Amsterdam, The Netherlands. His research focuses on pathophysiology of immune-mediated disorders of platelets (e.g. immune thrombocytopenia; ITP) and endothelium (e.g. Transfusion-related acute lung injury; TRALI).
Sanquin is the national blood service for Netherlands, knowledge institute in the field of blood, and internationally renowned research institute in the fields of blood transfusion medicine and immunology. This knowledge is applied for development and production of a range of pharmaceutical and diagnostic services.
MAT-BE-2600181 (ver.1) Feb 2026